Teemu J. Murtola, MD, PhD; Thea Veitonmäki, MD, PhD
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M19-0525.
Corresponding Author: Teemu J. Murtola, MD, PhD, Tampere University, Faculty of Medicine and Health Technology, FM1 Building, 3rd Floor, Teiskontie 35, PL 2000, Tampere 33521, Finland; e-mail, firstname.lastname@example.org.
Current Author Addresses: Dr. Murtola: Tampere University, Faculty of Medicine and Health Technology, FM1 Building, 3rd Floor, Teiskontie 35, PL 2000, Tampere 33521, Finland.
Dr. Veitonmäki: Tampere University Hospital, Department of Urology, Teiskontie 35, PL 2000, Tampere 33521, Finland.
Murtola TJ, Veitonmäki T. Aspirin and Prostate Cancer Mortality: The Role of Tumor Grading Misclassification?. Ann Intern Med. 2019;170:499–500. [Epub ahead of print 5 March 2019]. doi: https://doi.org/10.7326/M19-0525
Download citation file:
Published: Ann Intern Med. 2019;170(7):499-500.
Published at www.annals.org on 5 March 2019
Hematology/Oncology, Prostate Cancer.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use